Results 121 to 130 of about 7,713,923 (357)
Diagnostic Procedures In Immunodermatology
Most immunologic diseases are caused by the derailment of the humoral or cellular pathways of the immunologic defense system. This derailment results from numerous factors such as the inability of the patient to remove the pathogen; the consumption, defect, or deficiency in any component of these pathways, and the overproduction of any of the ...
Cormane, Rudi H., Asghar, Syed Shafi
openaire +2 more sources
OP0290 WHICH INFLAMED TISSUES EXPLAIN A POSITIVE SQUEEZE TEST OF THE METATARSOPHALANGEAL JOINTS? A LARGE IMAGING STUDY TO INCREASE UNDERSTANDING OF A COMMONLY PERFORMED DIAGNOSTIC PROCEDURE [PDF]
B. Van Dijk +6 more
openalex +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Development of a Diagnostic Procedure for Vehicle’s Built-in Electric Motors
Electric and hybrid vehicles, similarly to combustion engine ones, can experience malfunctions, yet preventive diagnostics for their electric motors are underdeveloped.
Balázs Baráth +3 more
doaj +1 more source
Validation of clinical exome sequencing in the diagnostic procedure of patients with intellectual disability in clinical practice. [PDF]
Ballesta-Martínez MJ +8 more
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Endoscopic submucosal dissection as a diagnostic procedure for a giant submucosal “sausage” causing dysphagia [PDF]
Martin Dahan +6 more
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source

